| Primary |
| Pain |
36.8% |
| Back Pain |
6.8% |
| Breakthrough Pain |
6.8% |
| Depression |
6.8% |
| Arthralgia |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Analgesia |
2.6% |
| Constipation |
2.6% |
| Hormone Replacement Therapy |
2.6% |
| Insomnia |
2.6% |
| Joint Swelling |
2.6% |
| Lung Neoplasm Malignant |
2.6% |
| Menopause |
2.6% |
| Neck Pain |
2.6% |
| Non-small Cell Lung Cancer |
2.6% |
| Obesity |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Cancer Pain |
1.7% |
| Complex Regional Pain Syndrome |
1.7% |
|
| Cardio-respiratory Arrest |
15.9% |
| Completed Suicide |
8.7% |
| Pharmaceutical Product Complaint |
8.7% |
| Jaundice Cholestatic |
7.2% |
| Pain |
5.8% |
| Vomiting |
5.8% |
| Withdrawal Syndrome |
5.8% |
| Hyperhidrosis |
4.3% |
| Nausea |
4.3% |
| Pruritus |
4.3% |
| Therapeutic Response Unexpected With Drug Substitution |
4.3% |
| Angina Pectoris |
2.9% |
| Cardiomyopathy |
2.9% |
| Drug Ineffective |
2.9% |
| Poisoning Deliberate |
2.9% |
| Product Formulation Issue |
2.9% |
| Product Substitution Issue |
2.9% |
| Pruritus Generalised |
2.9% |
| Respiratory Arrest |
2.9% |
| Abdominal Discomfort |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
27.5% |
| Drug Use For Unknown Indication |
21.1% |
| Cancer Pain |
14.8% |
| Pain |
12.0% |
| Breakthrough Pain |
4.9% |
| Arthralgia |
3.5% |
| Depression |
2.1% |
| Hypothyroidism |
2.1% |
| Back Pain |
1.4% |
| Diabetes Mellitus |
1.4% |
| Hypertension |
1.4% |
| Migraine |
1.4% |
| Musculoskeletal Discomfort |
1.4% |
| Colitis Ulcerative |
0.7% |
| Fibromyalgia |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Headache |
0.7% |
| Insomnia |
0.7% |
| Liver Transplant |
0.7% |
| Muscle Spasms |
0.7% |
|
| Completed Suicide |
16.0% |
| Jaundice Cholestatic |
10.0% |
| Respiratory Arrest |
10.0% |
| Death |
8.0% |
| Hyperaesthesia |
6.0% |
| Loss Of Consciousness |
6.0% |
| Rash Pruritic |
6.0% |
| Withdrawal Syndrome |
6.0% |
| Agitation |
4.0% |
| Intentional Drug Misuse |
4.0% |
| Narcotic Intoxication |
4.0% |
| Sinus Tachycardia |
4.0% |
| Cardiac Arrest |
2.0% |
| Constipation |
2.0% |
| Drug Abuse |
2.0% |
| Drug Dispensing Error |
2.0% |
| Incoherent |
2.0% |
| Incorrect Dose Administered |
2.0% |
| Jaundice |
2.0% |
| Medication Error |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Pain |
11.4% |
| Product Used For Unknown Indication |
9.0% |
| Multiple Myeloma |
6.0% |
| Non-small Cell Lung Cancer Metastatic |
4.9% |
| Fungal Infection |
4.6% |
| Breast Cancer |
4.4% |
| Nausea |
4.1% |
| Depression |
3.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Hypertension |
3.8% |
| Diabetes Mellitus |
3.5% |
| Diuretic Therapy |
2.7% |
| Bladder Cancer |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Analgesia |
2.2% |
| Analgesic Therapy |
2.2% |
| Complex Regional Pain Syndrome |
2.2% |
| Hypocalcaemia |
2.2% |
|
| Pain |
17.0% |
| Renal Failure |
7.5% |
| Respiratory Distress |
7.5% |
| Vomiting |
7.5% |
| Jugular Vein Thrombosis |
5.7% |
| Wrong Technique In Drug Usage Process |
5.7% |
| Abdominal Pain |
3.8% |
| Dyspnoea |
3.8% |
| Injection Site Pain |
3.8% |
| Multi-organ Failure |
3.8% |
| Platelet Count Decreased |
3.8% |
| Rectal Haemorrhage |
3.8% |
| Sepsis |
3.8% |
| Skin Exfoliation |
3.8% |
| Spinal Compression Fracture |
3.8% |
| Syncope |
3.8% |
| Tooth Fracture |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Accidental Exposure |
1.9% |
| Addison's Disease |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
57.1% |
| Back Pain |
19.0% |
| Back Disorder |
14.3% |
| Lung Neoplasm Malignant |
9.5% |
|
| Potentiating Drug Interaction |
40.0% |
| Drug Toxicity |
20.0% |
| Performance Status Decreased |
20.0% |
| Roux Loop Conversion |
20.0% |
|
